Tomas J. Heyman
Director, Akero Therapeutics, Inc.
Companies
- Legend BiotechBoard member Mar 18, 2026 to now1
- ExelixisBoard member Jun 2, 2023 to now2
- OptiNose, Inc.Board member Dec 4, 2020 to now3
- Akero Therapeutics, Inc.Board member Jun 11, 2020 to now4
- Xilio Therapeutics, Inc.Board member Sep 16, 2022 to Jun 13, 20235
- Invivyd, Inc.Board member Aug 5, 2021 to May 25, 20236
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Exelixis EXEL50,649 shares7$3.2M at $62.59May 27, 2026- Legend Biotech LEGN53,720 shares8$991.5K at $18.46Sep 24, 2026
- Akero Therapeutics, Inc.0 shares9Dec 9, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 24, 2026Granted 20,986 shares of Legend Biotech8
- May 27, 2026Granted 8,367 shares of Exelixis7
- Dec 9, 2025Returned to company 9,398 shares of Akero Therapeutics, Inc.9
- Jun 3, 2025Granted 9,398 shares of Akero Therapeutics, Inc.10
- May 29, 2025Granted 9,812 shares of Exelixis11
- May 21, 2025Sold 4,544 shares at $44.29 of Exelixis12
- May 31, 2024Granted 18,838 shares of Exelixis13
- Jun 16, 2023Sold 26,000 shares at $54.67 of Akero Therapeutics, Inc.14
- Jun 16, 2023Exercised options 26,000 shares at $25.04 of Akero Therapeutics, Inc.14
- May 31, 2023Granted 18,176 shares of Exelixis15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARLegend Biotech, Board member
- 2SEC EDGARExelixis, Board member
- 3SEC EDGAROptiNose, Inc., Board member
- 4
- 5
- 6SEC EDGARInvivyd, Inc., Board member
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jun 5, 2025
- 11SEC EDGARForm 4 filed May 30, 2025
- 12SEC EDGARForm 4 filed May 22, 2025
- 13SEC EDGARForm 4 filed Jun 4, 2024
- 14SEC EDGARForm 4 filed Jun 21, 2023
- 15SEC EDGARForm 4 filed Jun 2, 2023